Kabasurakudineer subjected to analysis for anti-viral properties, Centre tells HC

An analysis of Kabasurakudineer, a poly herbal preparation under Siddha form of medication, for its anti-viral properties is under way at the Regional Centre for Biotechnology in Faridabad. The results of the analysis are awaited. Another Siddha nutritional drink comprising turmeric, pepper and Amukkara, named as MAM, was also being tested at the International Centre for Genetic Engineering and Biotechnology in New Delhi for anti-viral properties. The results of that test was also yet to come.

The efficacy of other Siddha drugs such as Bramanda Bairava Mathirai, Adhathodai Manapagu, Thalisathy Chooranam, Nochi Kudineer, Athimathuram Choorana Maathirai, Amukkara Choorana Maathirai and Thippili Rasayanam were also being studied, according to an affidavit filed before the court on behalf of the Ministry of AYUSH.

After the completion of the trials by various agencies, the efficacy reports would be submitted to the Ministry. The Centre had increased the allocation of funds for Central Council for Research in Siddha (CCRS) at Arumbakkam in Chennai from ₹16.38 crore in 2011-12 to ₹35 crore in 2020-21.

Related posts:

Centre to fund new ayurveda research centre in Kerala 210-bedded Ayush Covid care centre in Mysuru first ayurvedic anti-diabetic drug from CSIR Start pension scheme for staff, HC tells Bhartiya Chikitsa Parishad AYUSH Ministry allotted a budge of Rs 1,939.76 crore